'The Food and Drug Administration has one responsibility: to keep Americans safe from harmful products. In 2000, however, the FDA failed to protect America’s women and girls,' Julie Marie Blake writes.
Food and Drug Administration
But the FDA also sidestepped the required testing; it never actually looked at the harms and risks associated with these drugs in their labeled use. For example, the FDA looked at a study that required women to have an ultrasound to determine gestational age before having a chemical— a sensible precaution because the risks skyrocket as pregnancy advances. But when the FDA approved chemical abortion drugs for use, the agency itself never required an ultrasound to verify gestational age.
As of 2021, the FDA no longer requires in-person prescribing or dispensing, or an in-person checkup, to determine ectopic pregnancies or gestational age. In 2000, the FDA required three in-person appointments to receive a chemical abortion. Now, abortionists do not needin-person interaction with a woman to prescribe chemical abortion drugs, and the drugs are often even sent through the mail .
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Food fight: FDA is redefining ‘healthy’ and food industry is pushing backLess saturated fat, less sodium, less added sugar -- manufacturers say almost no packaged foods would qualify under the agency’s new rules
Weiterlesen »
Eisai, Biogen say FDA grants priority review for Alzheimer's drug LecanemabJapanese drugmaker Eisai Co Ltd and its U.S. partner Biogen Inc said on Monday that the U.S. Food and Drug Administration granted priority review for traditional approval of their Alzheimer's treatment Lecanemab.
Weiterlesen »
Altria buying vape maker NJOY for $2.75BAltria will buy vape-maker NJOY and absorb the company’s NJOY ACE production as the only e-vapor product with market authorizations from the U.S. Food and Drug Administration (FDA).
Weiterlesen »
FDA will review Eisai and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early JulyFDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Weiterlesen »
Opinion | The Government’s Covid CasualtiesFrom WSJopinion: FDA delays carry human and financial costs, and examples are the fates of the Covid vaccine maker Novavax and the testing start-up Lucira
Weiterlesen »
In the mail?: Pro-life, pro-choice advocates turn attention to FDA’s abortion pill planThe next battleground on abortion lies at the post office — over a 150-year-old anti-vice law that some legal experts say expressly bars the mailing of abortion pills.
Weiterlesen »